The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement

Inclusion Criteria: * Age: Participants must be 55 years of age or older. * Ethnicity: Focused on African American individuals, but not exclusive. * Cognitive Status: Participants must have normal cognitive status, mild cognitive impairment (MCI), or subjective cognitive impairment (SCI). * Language: Participants must be fluent in English. * Location: Must reside in the Crenshaw, California area or\* be able to attend study-related activities in this location. \*online access is available for those not in this area. * Willingness to Participate: Participants must be willing to adhere to the study protocol, including attending assessments, participating in interventions, and completing questionnaires. Exclusion Criteria: * Cognitive Decline: Diagnosis of dementia or severe cognitive impairment that would interfere with the ability to participate in the study. * Physical Limitations: Any physical or medical condition that would preclude participation in the lifestyle interventions (e.g., severe mobility issues). * Recent Cancer Diagnosis: Diagnosis of cancer within the last three years, excluding stable cases of basal cell or squamous cell carcinoma of the skin, or stable prostate cancer. * Pregnancy: Current pregnancy or planning to become pregnant during the study period. * Mental Health: Diagnosis of severe psychiatric disorders such as schizophrenia or bipolar disorder that might interfere with participation. * Substance Abuse: Current substance abuse or dependency that could impact participation. * Hearing Impairment: Uncorrected hearing loss that would limit the ability to communicate and participate in the study. * Non-English Speaking: Inability to participate in English-language oral and written cognitive assessments. * Participation in Another Study: Currently enrolled in another clinical trial that could interfere with the INSPIRE Study. * Life expectancy less than 3 years * Unwillingness to share medical and laboratory information.